- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Griffith & Werner Inc. Invests $2.64 Million in AbbVie Inc.
The investment firm acquired a new stake in the pharmaceutical company's shares.
Published on Mar. 4, 2026
Got story updates? Submit your updates here. ›
Griffith & Werner Inc., a hedge fund, acquired a new stake in shares of AbbVie Inc. (NYSE:ABBV) in the third quarter, according to the company's recent SEC filing. The firm purchased 12,046 shares of AbbVie's stock, valued at approximately $2.64 million. AbbVie now comprises 1.4% of Griffith & Werner's holdings, making it the 26th largest position in the fund's portfolio.
Why it matters
This investment highlights the continued interest and confidence in AbbVie from institutional investors. As a major pharmaceutical company with a diverse product portfolio, AbbVie's stock has been a popular choice for hedge funds and other institutional investors looking to gain exposure to the healthcare sector.
The details
According to the SEC filing, Griffith & Werner Inc. purchased the 12,046 shares of AbbVie in the third quarter. This new stake represents approximately 1.4% of the firm's total holdings, making AbbVie the 26th largest position in the fund's portfolio. The shares were valued at around $2.64 million at the time of purchase.
- Griffith & Werner Inc. acquired the new stake in AbbVie Inc. in the third quarter of 2026.
The players
Griffith & Werner Inc.
A hedge fund that recently acquired a new stake in shares of AbbVie Inc.
AbbVie Inc.
A global, research-driven biopharmaceutical company that focuses on discovering, developing, and commercializing therapies for complex and often chronic medical conditions.
The takeaway
This investment by Griffith & Werner Inc. demonstrates the continued appeal of AbbVie's stock among institutional investors. As a major player in the pharmaceutical industry, AbbVie's diverse product portfolio and strong financial performance have made it a attractive option for hedge funds and other investment firms looking to gain exposure to the healthcare sector.
